Xenbase is undergoing scheduled maintenance Wednesday, June 14 and Thursday, June 15, 2023. Xenbase will be unavailable on those days.

 Click on this message to dismiss it.
Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-23250

Xla Wt + VP16-ventx2.2-GR + DEX, McLin VA et al. (2007)

Experiment + Assay: Xla Wt + VP16-ventx2.2-GR + DEX + NF35/36-37 and 38 (in situ hybridization)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
mRNA injection Tg(VP16-ventx2.2-GR) ventx2.2.L
ventx2.2.S
 NF stage 6 (32-cell) blastomere D2.1.1
chemical dexamethasone
NF stage 7 embryo
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 35 and 36 to NF stage 37 and 38  
Expression Phenotypes (3):
decreased amount nr1h5.L expression in liver
decreased amount pdx1.L expression in dorsal pancreatic bud
decreased amount pdx1.L expression in ventral pancreatic bud
Source: Fig.S.2.C
Article: XB-ART-35992, PubMed